ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305802 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305802; 2) Community: the network communities that were significantly associated with the response to NSC 305802; 3) Molecule: the relationships between components within communities and NSC 305802; 4) MDR: the compounds that were significantly associated with the NSC 305802.

NSC Compound Enrichment Correlation
NSC 644221 Null 0.0186186224062459 0.070485317
NSC 648365 Insulin-Methotrexate conjugate 0.0186186224062459 0.48569068
NSC 668432 Null 0.0186186224062459 -0.056635246
NSC 671660 Null 0.0186186224062459 0.027072091
NSC 676343 Null 0.0186186224062459 -0.011188213
NSC 679600 Null 0.0186186224062459 -0.0457249
NSC 680931 Null 0.0186186224062459 0.47804562
NSC 683692 .alpha.-D-Glucopyranoside, phenylmethyl 2-acetylamino-2-deoxy- 3-O-[[2-[[2-[1-(aminocarbonyl)-4-[[5-[(1-nitro- 9-acridinyl)amino]pentyl]amino]-4-oxobutyl]amino]- 1-methyl-2-oxoethyl]amino]-1-methyl-2 0.0186186224062459 0.37948533
NSC 693547 2-Amino-4-(2-hydroxy-4-methylphenyl)-5-phenylpyrimidine 0.0186186224062459 0.33264611
NSC 693985 Thymine, 1-[1,2-bis(ethoxycarbonyl)ethenyl]- 3-propynyl-, (Z)- 0.0186186224062459 0.13318202
Total:122  Current:58    [First] [Prev] [Next] [Last]